Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Martine E.D. Chamuleau, MD, Marcel Nijland, MD, Josée M Zijlstra, MD, Rogier Mous, MD PhD, P.J. Lugtenburg, Daan Dierickx, MD PhD, Gustaaf van Imhoff, MD PhD, Joost Vermaat, MD PhD, Katerina Bakunina, Erik W.A. Marijt, MD, Otto Visser, MDPhD, Caroline Mandigers, MD, Yavuz Bilgin, MDPhD, Coreline Burggraaff, Otto Hoekstra, MDPhD, Daphne de Jong, Prof Dr, Marie José Kersten, MD

Blood (2018) 132 (Supplement 1): 786.

https://doi.org/10.1182/blood-2018-99-110240

Published: 2018

Journal Articles

Effectiveness of a Strategy to Proceed to Allogeneic Stem Cell Transplantation in All Elderly AML Patients Treated with Intensive Chemotherapy: Only Patients in Complete Remission After First Induction Show Long Term Survival.

Peter A. Von Dem Borne, MD, PhD, Constantijn J.M. Halkes, MD, PhD, Erik W.A. Marijt, MD, PhD, Sabina Kersting, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, J.Hendrik Veelken, MD, PhD

Blood (2012) 120 (21): 3085.

https://doi.org/10.1182/blood.V120.21.3085.3085

Published: 2012

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial

Blood (2012) 120 (21): 964.

https://doi.org/10.1182/blood.V120.21.964.964

Published: 2012

Journal Articles

Quantitative Monitoring of NPM1A Mutations Can Be Used to Guide Immunotherapeutic Interventions After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Jessica C. Harskamp, MD, Joya E. Nahon, Andrea M. Siegel, Hans L. Vos, PhD, Piëette P. Deutz-Terlouw, J.Hendrik Veelken, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2011) 118 (21): 3061.

https://doi.org/10.1182/blood.V118.21.3061.3061

Published: 2011

Journal Articles

Primary Antibody Responses Against the Novel Pandemic H1N1 and Secondary Antibody Responses Against Seasonal H1N1 Can Be Induced by Vaccination In Patients Early After Allogeneic Stem Cell Transplantation

Roselke E Klinkenberg, MD, Marieke Griffioen, PhD, Edith D van der Meijden, Erik W.A. Marijt, MD, PhD, J.H. Frederik Falkenburg, MD, PhD

Blood (2010) 116 (21): 1273.

https://doi.org/10.1182/blood.V116.21.1273.1273

Published: 2010

Journal Articles

Eradication of Recipient CMV Specific T Cells by Donor Lymphocyte Infusion Does Not Impair Protective Immunity In Patients Transplanted with a CMV Negative Donor Due to An Early Donor Derived Primary CMV Specific T Cell Response

Pim L.J. van der Heiden, MD, Jessica C. Harskamp, Esther H.M. van Egmond, Piëtte P. Deutz-Terlouw, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2010) 116 (21): 834.

https://doi.org/10.1182/blood.V116.21.834.834

Published: 2010

Journal Articles

T Cell Chimerism After T Cell Depleted Allogeneic Stem Cell Transplantation Is Influenced by Immunological Factors Including the Conditioning Regimen, CMV Serostatus and GvHD and Does Significantly Bias Overall Chimerism Status

Jessica C. Harskamp, MD, Pim L.J. van der Heiden, MD, Esther H.M. van Egmond, Sabrina A.J. Veld, Hans L. Vos, PhD, Constantijn J.M. Halkes, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2010) 116 (21): 1321.

https://doi.org/10.1182/blood.V116.21.1321.1321

Published: 2010

Journal Articles

Myeloid Chimerism Reflects Engraftment of Donor Hematopoiesis, Whereas T Cell Chimerism Reflects Survival and Expansion of Donor and Recipient Residual Mature T Cells Early After T Cell Depleted Allogeneic Stem Cell Transplantation.

Jessica C. Harskamp, Esther H.M. van Egmond, Hans L. Vos, PhD, Stijn J.M. Halkes, MD, PhD, Roel Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2009) 114 (22): 4475.

https://doi.org/10.1182/blood.V114.22.4475.4475

Published: 2009

Journal Articles

The Effect of Donor Lymphocyte Infusion Dose on the Occurrence of Severe Life-Threatening Acute Graft-Versus-Host Disease Early after Reduced Intensity Conditioning T Cell Depleted Stem Cell Transplantation.

Peter A. Von Dem Borne, C.W.J. Ingrid Starrenburg, M. Floor Beaumont, Stijn J.M. Halkes, Erik W.A. Marijt, J.H. Frederik Falkenburg, Roelof Willemze

Blood (2008) 112 (11): 2218.

https://doi.org/10.1182/blood.V112.11.2218.2218

Published: 2008

Journal Articles

Donor Lymphocyte Infusion for Mixed Chimerism or Residual Disease after Reduced-Intensity T Cell Depleted Stem Cell Transplantation Results in Conversion to Full Donor Chimerism Combined with Graft Versus Tumor Responses and Limited GVHD.

Peter A. von dem Borne, MD, PhD, Ingrid Starrenburg, Erik W.A. Marijt, Stijn Halkes, J.H. Frederik Falkenburg, Roel Willemze

Blood (2007) 110 (11): 1652.

https://doi.org/10.1182/blood.V110.11.1652.1652

Published: 2007

Journal Articles

Leukemic Blasts Acting as Host Antigen Presenting Cells Trigger a Combined CD4 and CD8 Allo-Immune Response Directed Against Mismatched HLA Class I.

Avital Amir, MD, Renate S. Hagendoorn, Erik W.A. Marijt, Roelof Willemze, J.H. Frederik Falkenburg, Mirjam Heemskerk

Blood (2007) 110 (11): 5030.

https://doi.org/10.1182/blood.V110.11.5030.5030

Published: 2007

Journal Articles

Efficient Induction and Isolation of CMV-Specific CD8+ T Cells from CMV Seronegative Donors for the Treatment of CMV Reactivation in CMV Seropositive Patients Transplanted with a CMV Seronegative Donor.

Inge Jedema, Marian van de Meent, Pim L.J. van der Heiden, Erik W.A. Marijt, Pauline Meij, Roel Willemze, J.H. Frederik Falkenburg

Blood (2007) 110 (11): 1053.

https://doi.org/10.1182/blood.V110.11.1053.1053

Published: 2007

Journal Articles

Detection of Varicella Zoster Virus Specific CD8 T Cells in Patients after T Cell Depleted Allogeneic Stem Cell Transplantation by a Novel Epitope Screening Technology.

P.L.J. van der Heiden, M. Kester, M.W.A.G. van der Hoorn, W.M.E. Haarman, H.E. Barnby-Porritt, A. Banaszek, C.E. Napper, Erik W.A. Marijt, Roelof Willemze, J.H. Frederik Falkenburg, Mirjam Heemskerk

Blood (2007) 110 (11): 1060.

https://doi.org/10.1182/blood.V110.11.1060.1060

Published: 2007

Journal Articles

GVHD in HLA-A2 Mismatched Transplantation Caused by a Combined CD8 Response Directed Against HLA-A2 and a CD4 Response Recognizing an HLA-A2 Derived Peptide in HLA-DR1.

Avital Amir, Menno A.W.G. van der Hoorn, Erik W.A. Marijt, Michel G.D. Kester, Roelof Willemze, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Blood (2006) 108 (11): 5164.

https://doi.org/10.1182/blood.V108.11.5164.5164

Published: 2006

Journal Articles

Profound T Cell Depletion Does Not Eradicate CMV Specific CD8 T Cells Responsible for Protective Immunity to CMV after T Cell Depleted Allogeneic Stem Cell Transplantation.

Pim L.J. van der Heiden, Jayant S. Kalpoe, Wilmy M.E. Haarman, Sonja M. Opdam, Roelof Willemze, J.H. Frederik Falkenburg, Erik W.A. Marijt

Blood (2006) 108 (11): 2920.

https://doi.org/10.1182/blood.V108.11.2920.2920

Published: 2006

Journal Articles

Donor Lymphocyte Infusion (DLI) for Mixed Chimerism 6 Months after T Cell Depleted Allogeneic Stem Cell Transplantation (TCD alloSCT) May Prevent Relapse.

Erik W.A. Marijt, MD, PhD, Peter A. Von Dem Borne, MD PhD, Renee M.Y. Barge, MD PhD, Piette P. Deutz, M. Floor Beaumont, C.W.J. Ingrid Starrenburg, Willem E. Fibbe, MD PhD, Roelof Willemze, MD PhD, J.H. Frederik Falkenburg, MD PhD

Blood (2006) 108 (11): 3674.

https://doi.org/10.1182/blood.V108.11.3674.3674

Published: 2006

Journal Articles

A Two Step Nonmyeloablative Allogeneic Transplantation Protocol Using In Vitro T-Cell Depleted Mobilized Stem Cells Followed by Donor Lymphocyte Infusions in Patients with Advanced CLL.

Renee M.Y. Barge, MD, PhD, Mels Hoogendoorn, MD, Erik W.A. Marijt, MD, PhD, Floor Beaumont, Ingrid Starrenburg, Willem Smit, MD, PhD, Ward Posthuma, MD, PhD, Willem E. Fibbe, MD, PhD, Frederik Falkenburg, MD, PhD, Roelof Willemze, MD, PhD

Blood (2005) 106 (11): 5396.

https://doi.org/10.1182/blood.V106.11.5396.5396

Published: 2005

NARROW

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Effectiveness of a Strategy to Proceed to Allogeneic Stem Cell Transplantation in All Elderly AML Patients Treated with Intensive Chemotherapy: Only Patients in Complete Remission After First Induction Show Long Term Survival.

Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial

Quantitative Monitoring of NPM1A Mutations Can Be Used to Guide Immunotherapeutic Interventions After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Primary Antibody Responses Against the Novel Pandemic H1N1 and Secondary Antibody Responses Against Seasonal H1N1 Can Be Induced by Vaccination In Patients Early After Allogeneic Stem Cell Transplantation

Eradication of Recipient CMV Specific T Cells by Donor Lymphocyte Infusion Does Not Impair Protective Immunity In Patients Transplanted with a CMV Negative Donor Due to An Early Donor Derived Primary CMV Specific T Cell Response

T Cell Chimerism After T Cell Depleted Allogeneic Stem Cell Transplantation Is Influenced by Immunological Factors Including the Conditioning Regimen, CMV Serostatus and GvHD and Does Significantly Bias Overall Chimerism Status

Myeloid Chimerism Reflects Engraftment of Donor Hematopoiesis, Whereas T Cell Chimerism Reflects Survival and Expansion of Donor and Recipient Residual Mature T Cells Early After T Cell Depleted Allogeneic Stem Cell Transplantation.

The Effect of Donor Lymphocyte Infusion Dose on the Occurrence of Severe Life-Threatening Acute Graft-Versus-Host Disease Early after Reduced Intensity Conditioning T Cell Depleted Stem Cell Transplantation.

Donor Lymphocyte Infusion for Mixed Chimerism or Residual Disease after Reduced-Intensity T Cell Depleted Stem Cell Transplantation Results in Conversion to Full Donor Chimerism Combined with Graft Versus Tumor Responses and Limited GVHD.

Leukemic Blasts Acting as Host Antigen Presenting Cells Trigger a Combined CD4 and CD8 Allo-Immune Response Directed Against Mismatched HLA Class I.

Efficient Induction and Isolation of CMV-Specific CD8+ T Cells from CMV Seronegative Donors for the Treatment of CMV Reactivation in CMV Seropositive Patients Transplanted with a CMV Seronegative Donor.

Detection of Varicella Zoster Virus Specific CD8 T Cells in Patients after T Cell Depleted Allogeneic Stem Cell Transplantation by a Novel Epitope Screening Technology.

GVHD in HLA-A2 Mismatched Transplantation Caused by a Combined CD8 Response Directed Against HLA-A2 and a CD4 Response Recognizing an HLA-A2 Derived Peptide in HLA-DR1.

Profound T Cell Depletion Does Not Eradicate CMV Specific CD8 T Cells Responsible for Protective Immunity to CMV after T Cell Depleted Allogeneic Stem Cell Transplantation.

Donor Lymphocyte Infusion (DLI) for Mixed Chimerism 6 Months after T Cell Depleted Allogeneic Stem Cell Transplantation (TCD alloSCT) May Prevent Relapse.

A Two Step Nonmyeloablative Allogeneic Transplantation Protocol Using In Vitro T-Cell Depleted Mobilized Stem Cells Followed by Donor Lymphocyte Infusions in Patients with Advanced CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only